top of page

Search

Long Term Efficacy of Deucravacitinib

Jul 13, 20231 min read

Dr. Ronald B. Vender discusses the TYK2 inhibitor deucravacitinib at the World Congress of Dermatology 2023 in Singapore.

Recent Posts

VIDEO: Oral roflumilast efficacious in treating moderate-to-severe plaque PsO

VIDEO: Dermocosmetics as adjunctive therapy improves skin sensitivity, QoL in acne patients

VIDEO: GP, Dermatologist discuss therapeutic options for AD

Comments

bottom of page